Lactose Intolerance: Understanding The Causes, Symptoms, And Practical Solutions
Considering the fact that about seventy per cent of the world population, primarily Asian, African and South American people ...
Le Lézard14h
Pfizer's BRAFTOVI® Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...